Skip to navigation Skip to content

COVID-19 Information for Healthcare Providers

Share

In this article

COViMS

COViMS (COVID-19 Infections in MS & Related Diseases) is a joint effort of the National MS Society, Consortium of MS Centers and MS Society of Canada to capture information on outcomes of people with MS and other CNS demyelinating diseases (Neuromyelitis Optica, or MOG antibody disease) who have developed COVID-19.  
 
Collecting data on those with MS, NMO or MOG antibody disease who have highly suspicious or laboratory confirmed COVID-19 remains crucial.  Please report only after a minimum of 7 days and sufficient time has passed to observe the disease course through resolution of acute illness or death.  View current data.

Enter a case

Enter a case

COVER-MS

The National MS Society is partnering with the iConquerMS Patient-Powered Research Network to gather data on how well the COVID-19 vaccine is tolerated in the MS population. COVER-MS a study that assesses the experiences of those diagnosed with MS who received the COVID-19 vaccines. People with MS who have received the vaccine can visit the iConquerMS website to share their experience.

Learn more

Learn more

Overview

We are closely watching the COVID-19 situation and taking action as we all move forward. We know that the best information for someone living with MS about their unique situation comes from their healthcare providers, and we refer them to you first whenever possible. But we also know that due to the unique circumstances around COVID-19, that may be more difficult.

We are here to partner with you to provide your patients with a trustworthy platform of fact-based information about COVID19 and multiple sclerosis, including information on the COVID-19 vaccine. The MS Navigator® program is an excellent resource for MS-specific support and information nationwide.

Follow us on Twitter for the latest COVID-19 updates.  Twitter @mssocietyhcp

COVID-19 Webinars for MS Healthcare Providers

Personalized Approach to Preventing COVID-19 in the Immunocompromised 

On March 3, 2022 the National MS Society and Consortium of MS Centers hosted an expert-led virtual discussion on tailoring COVID-19 prevention strategies to the needs of each patient. Discussion topics included the role of personalized vaccine schedules, pre-exposure prophylactics and the role of biomarkers in clinical decision making.   

Listen to the recording here

 

From pandemic to endemic: How do the immunocompromised live with SARS-CoV-2

On February 17, 2022 the National MS Society and Consortium of MS Centers hosted an expert-led virtual discussion on post-pandemic life, what that means for the general population and the implications for those who are immunocompromised.

Listen to the recording here

COVID-19 Resources for Healthcare Providers

COVID-19 Resources for People with MS

Telehealth

Share

© 2023 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.